Literature DB >> 21300828

Anthelmintics are substrates and activators of nematode P glycoprotein.

Dominique Kerboeuf1, Fabrice Guégnard.   

Abstract

P glycoproteins (Pgp), members of the ABC transporter superfamily, play a major role in chemoresistance. In nematodes, Pgp are responsible for resistance to anthelmintics, suggesting that they are Pgp substrates, as they are in mammalian cells. However, their binding to nematode Pgp and the functional consequences of this interaction have not been investigated. Our study showed that levamisole and most of the macrocyclic lactones (MLs) are Pgp substrates in nematodes. Ivermectin, although a very good substrate in mammalian cells, is poorly transported. In contrast to their inhibitory effect on mammalian Pgp, these drugs had a stimulatory effect on the transport activity of the reference Pgp substrate rhodamine 123 (R123) in the nematode. This may be due to a specific sequence of nematode Pgp, which shares only 44% identity with mammalian Pgp. Other factors, such as the affinity of anthelmintics for Pgp and their concentration in the Pgp microenvironment, could also differ in nematodes, as suggested by the specific relationship observed between the octanol-water partition coefficient (log P) of MLs and R123 efflux. Nevertheless, some similarities were also observed in the functional activities of the mammalian and nematode Pgp. As in mammalian cells, substrates known to bind the H site (Hoechst 33342 and colchicine) activated the R site, resulting in an increased R123 efflux. Our findings thus show that ML anthelmintics, which inhibit Pgp-mediated efflux in mammals, activate transport activity in nematodes and suggest that several substituents in the ML structure are involved in modulating the stimulatory effect.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21300828      PMCID: PMC3088189          DOI: 10.1128/AAC.01477-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  66 in total

1.  Drug resistance is affected by colocalization of P-glycoproteins in raft-like structures unexpected in eggshells of the nematode Haemonchus contortus.

Authors:  Mickaël Riou; Fabrice Guégnard; Pierre-Yves Sizaret; Yves Le Vern; Dominique Kerboeuf
Journal:  Biochem Cell Biol       Date:  2010-06       Impact factor: 3.626

2.  Cinchonine, a potent efflux inhibitor to circumvent anthracycline resistance in vivo.

Authors:  P Genne; M T Dimanche-Boitrel; R Y Mauvernay; G Gutierrez; O Duchamp; J M Petit; F Martin; B Chauffert
Journal:  Cancer Res       Date:  1992-05-15       Impact factor: 12.701

3.  Relationships between sterol/phospholipid composition and xenobiotic transport in nematodes.

Authors:  Mickaël Riou; Isabelle Grasseau; Elisabeth Blesbois; Dominique Kerboeuf
Journal:  Parasitol Res       Date:  2007-02-09       Impact factor: 2.289

4.  The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor.

Authors:  A Didier; F Loor
Journal:  Anticancer Drugs       Date:  1996-09       Impact factor: 2.248

5.  P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

Authors:  A H Schinkel; E Wagenaar; C A Mol; L van Deemter
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

6.  Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123.

Authors:  C Ludescher; J Thaler; D Drach; J Drach; M Spitaler; C Gattringer; H Huber; J Hofmann
Journal:  Br J Haematol       Date:  1992-09       Impact factor: 6.998

7.  MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin.

Authors:  Alain Roulet; Olivier Puel; Stéphane Gesta; Jean-François Lepage; Marlene Drag; Mark Soll; Michel Alvinerie; Thierry Pineau
Journal:  Eur J Pharmacol       Date:  2003-01-24       Impact factor: 4.432

8.  Characterization of phosphorylation-defective mutants of human P-glycoprotein expressed in mammalian cells.

Authors:  U A Germann; T C Chambers; S V Ambudkar; T Licht; C O Cardarelli; I Pastan; M M Gottesman
Journal:  J Biol Chem       Date:  1996-01-19       Impact factor: 5.157

9.  An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene.

Authors:  K H Choi; C J Chen; M Kriegler; I B Roninson
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

10.  P-glycoprotein interfering agents potentiate ivermectin susceptibility in ivermectin sensitive and resistant isolates of Teladorsagia circumcincta and Haemonchus contortus.

Authors:  D J Bartley; H McAllister; Y Bartley; J Dupuy; C Ménez; M Alvinerie; F Jackson; A Lespine
Journal:  Parasitology       Date:  2009-06-24       Impact factor: 3.234

View more
  18 in total

Review 1.  Moxidectin and the avermectins: Consanguinity but not identity.

Authors:  Roger Prichard; Cécile Ménez; Anne Lespine
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-04-14       Impact factor: 4.077

Review 2.  P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: Prospects for reversing transport-dependent anthelmintic resistance.

Authors:  Anne Lespine; Cécile Ménez; Catherine Bourguinat; Roger K Prichard
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2011-11-07       Impact factor: 4.077

3.  Killing them with kindness? In-hive medications may inhibit xenobiotic efflux transporters and endanger honey bees.

Authors:  David J Hawthorne; Galen P Dively
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

4.  Discovery of Cinnamylidene Derivative of Rhodanine with High Anthelmintic Activity against Rhabditis sp.

Authors:  Waldemar Tejchman; Przemysław Kołodziej; Justyna Kalinowska-Tłuścik; Wojciech Nitek; Grzegorz Żuchowski; Anna Bogucka-Kocka; Ewa Żesławska
Journal:  Molecules       Date:  2022-03-27       Impact factor: 4.411

5.  Macrocyclic lactones differ in interaction with recombinant P-glycoprotein 9 of the parasitic nematode Cylicocylus elongatus and ketoconazole in a yeast growth assay.

Authors:  Maximiliane Kaschny; Janina Demeler; I Jana I Janssen; Tetiana A Kuzmina; Bruno Besognet; Theo Kanellos; Dominique Kerboeuf; Georg von Samson-Himmelstjerna; Jürgen Krücken
Journal:  PLoS Pathog       Date:  2015-04-07       Impact factor: 6.823

6.  Effects of in vitro exposure to ivermectin and levamisole on the expression patterns of ABC transporters in Haemonchus contortus larvae.

Authors:  Ali Raza; Steven R Kopp; Neil H Bagnall; Abdul Jabbar; Andrew C Kotze
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2016-03-23       Impact factor: 4.077

7.  PGP expression in Cooperia oncophora before and after ivermectin selection.

Authors:  Marlene Areskog; Annie Engström; Jonas Tallkvist; Georg von Samson-Himmelstjerna; Johan Höglund
Journal:  Parasitol Res       Date:  2013-06-15       Impact factor: 2.289

8.  Haemonchus contortus P-glycoproteins interact with host eosinophil granules: a novel insight into the role of ABC transporters in host-parasite interaction.

Authors:  Mohamed Issouf; Fabrice Guégnard; Christine Koch; Yves Le Vern; Alexandra Blanchard-Letort; Hua Che; Robin N Beech; Dominique Kerboeuf; Cedric Neveu
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

9.  Drug-efflux and target-site gene expression patterns in Haemonchus contortus larvae able to survive increasing concentrations of levamisole in vitro.

Authors:  Ranbir S Sarai; Steven R Kopp; Glen T Coleman; Andrew C Kotze
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-03-13       Impact factor: 4.077

10.  Characterisation of P-glycoprotein-9.1 in Haemonchus contortus.

Authors:  Pablo Godoy; Hua Che; Robin N Beech; Roger K Prichard
Journal:  Parasit Vectors       Date:  2016-01-28       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.